Snapshot
- A 40-year-old woman presents to the urgent care for excessive fatigue and jaundice. She reports that she had felt fatigued for months. Recently, she noticed that her skin is more orange. On physical exam, she is noted to have scleral icterus and jaundice. Laboratory results reveal transaminitis. Anti-smooth muscle antibodies were negative, but a liver biopsy showed granulomatous inflammation of the bile ducts.
Introduction
- Overview
- primary biliary cholangitis (PBC) is a granulomatous autoimmune condition resulting in destruction of the interlobular bile ducts
- also known as primary biliary cirrhosis
- primary biliary cholangitis (PBC) is a granulomatous autoimmune condition resulting in destruction of the interlobular bile ducts
- Epidemiology
- demographics
- female > male
- middle-aged (>40 years of age)
- risk factors
- family history
- demographics
- Pathogenesis
- autoimmune attack on anti-mitochondrial antigens on biliary epithelial cells
- autoantibodies
- anti-mitochondrial antibodies (AMAs)
- Associated conditions
- other autoimmune diseases
- CREST syndrome
- rheumatoid arthritis
- celiac disease
- Hashimoto thyroiditis
- other autoimmune diseases
- scleroderma
Presentation
- Symptoms
- Physical exam
- inspection
- jaundice
- hepatosplenomegaly
- inspection
- may have xanthomas or xanthelasma
Imaging
- Ultrasound
- indication
- to assess for hepatobiliary disease
- views
- right upper quadrant
- findings
- cirrhosis, including increased nodularity, atrophy, or hypertrophy
- distinguish between intra and extrahepatic biliary obstruction
- indication
- ERCP (endoscopic retrograde cholangiopancreatography)
- indication
- ultrasound is inconclusive, or concern for gallstones
- findings
- extrahepatic ducts appear grossly normal
- indication
- contrast to “string of beads” in primary sclerosing cholangitis
Studies
- Serum labs
- liver function tests showing cholestasis pattern
- ↑ direct bilirubin
- ↑ alkaline phosphatase
- autoantibodies
- + anti-mitochondrial antibody (AMA)
- 90-95% sensitivity
- > 99% specificity
- + anti-smooth muscle antibody (ASMA)
- in 50% of patients
- + anti-nuclear antibody (ANA)
- in 50% of patients
- + anti-mitochondrial antibody (AMA)
- ↑ IgM
- ↑ cholesterol
- liver function tests showing cholestasis pattern
- Invasive studies
- Diagnosis with 2 or more of
- alkaline phosphatase > 1.5x upper limit of normal for 6 months or more
- + AMA in serum
- liver biopsy showing signs of PBC
Differential
- Hemochromatosis
- key distinguishing factor
- triad of cirrhosis, diabetes, and skin bronze pigmentation
- key distinguishing factor
- Wilson disease
- key distinguishing factors
- patients typically present before age 40
- key distinguishing factors
- cirrhosis, neurologic disease, psychiatric disease, and Kayser-Fleischer rings in the eyes
Treatment
- Lifestyle
- avoidance of alcohol
- vaccination against hepatitis A and B
- Medical
- ursodeoxycholic acid
- indications
- all patients
- indications
- cholestyramine
- indications
- pruritus
- indications
- ursodeoxycholic acid
- Surgical
- liver transplantation
- indications
- decompensated liver disease
- indications
- liver transplantation
- severe pruritus refractory to other therapies
Complications
- Portal hypertension
- Cirrhosis
- Osteoporosis
- monitor with DEXA scan
- supplement with vitamin D3